Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Nonallergic Rhinitis Companies

Nonallergic Rhinitis companies focus on developing solutions for individuals experiencing nasal inflammation unrelated to allergies. These companies contribute to the advancement of treatments that address the complexities of nonallergic rhinitis for improved patient comfort.

Nonallergic Rhinitis Market

Latest Nonallergic Rhinitis Companies Updates:

November 2018: AstraZeneca sold its rights to the asthma drug Alvesco (ciclesonide) and nasal sprays Omnaris and Zetonna (ciclesonide) to Covis Pharma for USD 350 million. This move allowed AstraZeneca to focus resources on developing new medications for unmet needs.

October 2023: Glenmark Pharmaceuticals launched its nasal corticosteroid spray, Flixonase Nasal Spray (fluticasone propionate), in the Indian market for the treatment of nonallergic rhinitis. This launch provides a new treatment option for Indian patients suffering from the condition.

June 2023: Sanofi received FDA approval for its nasal corticosteroid spray, Dymista (fluticasone propionate and azelastine hydrochloride), for the treatment of nonallergic rhinitis in adults and adolescents aged 12 years and older. This approval expands Dymista's reach beyond its previous indication for allergic rhinitis.

List of Nonallergic Rhinitis Key companies in the market:

Pfizer Inc (U.S.)

Progenics Pharmaceuticals (U.S.)

GlaxoSmithKline (U.K.)

Sucampo Pharmaceuticals Inc (U.S.)

Ironwood Pharmaceuticals (U.S.)

Sanofi (France)

Salix Pharmaceuticals Ltd (U.S.)

Bayer (Germany)

Nonallergic Rhinitis Market Highlights:

Nonallergic Rhinitis Market Size

Nonallergic Rhinitis Market Trends

Nonallergic Rhinitis Market Analysis

Nonallergic Rhinitis Market Share

Nonallergic Rhinitis Market Highlights:

Nonallergic Rhinitis Market Trends

Nonallergic Rhinitis Market Analysis

Nonallergic Rhinitis Market Share

Nonallergic Rhinitis Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.